BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22703186)

  • 1. The application of nonsense-mediated mRNA decay inhibition to the identification of breast cancer susceptibility genes.
    Johnson JK; Waddell N; ; Chenevix-Trench G
    BMC Cancer; 2012 Jun; 12():246. PubMed ID: 22703186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsense-mediated mRNA decay efficiency varies in choroideremia providing a target to boost small molecule therapeutics.
    Sarkar H; Mitsios A; Smart M; Skinner J; Welch AA; Kalatzis V; Coffey PJ; Dubis AM; Webster AR; Moosajee M
    Hum Mol Genet; 2019 Jun; 28(11):1865-1871. PubMed ID: 30689859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsense suppression induces read-through of a novel BMPR1A variant in a Chinese family with hereditary colorectal cancer.
    Wang Z; Shi J; Tao D; Xie S; Yang Y; Liu Y
    Ann Hum Genet; 2024 Jul; 88(4):300-306. PubMed ID: 38192234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to get away with nonsense: Mechanisms and consequences of escape from nonsense-mediated RNA decay.
    Dyle MC; Kolakada D; Cortazar MA; Jagannathan S
    Wiley Interdiscip Rev RNA; 2020 Jan; 11(1):e1560. PubMed ID: 31359616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation.
    Tarpey PS; Raymond FL; Nguyen LS; Rodriguez J; Hackett A; Vandeleur L; Smith R; Shoubridge C; Edkins S; Stevens C; O'Meara S; Tofts C; Barthorpe S; Buck G; Cole J; Halliday K; Hills K; Jones D; Mironenko T; Perry J; Varian J; West S; Widaa S; Teague J; Dicks E; Butler A; Menzies A; Richardson D; Jenkinson A; Shepherd R; Raine K; Moon J; Luo Y; Parnau J; Bhat SS; Gardner A; Corbett M; Brooks D; Thomas P; Parkinson-Lawrence E; Porteous ME; Warner JP; Sanderson T; Pearson P; Simensen RJ; Skinner C; Hoganson G; Superneau D; Wooster R; Bobrow M; Turner G; Stevenson RE; Schwartz CE; Futreal PA; Srivastava AK; Stratton MR; Gécz J
    Nat Genet; 2007 Sep; 39(9):1127-33. PubMed ID: 17704778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome profiling of UPF3B/NMD-deficient lymphoblastoid cells from patients with various forms of intellectual disability.
    Nguyen LS; Jolly L; Shoubridge C; Chan WK; Huang L; Laumonnier F; Raynaud M; Hackett A; Field M; Rodriguez J; Srivastava AK; Lee Y; Long R; Addington AM; Rapoport JL; Suren S; Hahn CN; Gamble J; Wilkinson MF; Corbett MA; Gecz J
    Mol Psychiatry; 2012 Nov; 17(11):1103-15. PubMed ID: 22182939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsense-mediated RNA decay: an emerging modulator of malignancy.
    Tan K; Stupack DG; Wilkinson MF
    Nat Rev Cancer; 2022 Aug; 22(8):437-451. PubMed ID: 35624152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular calcium regulates nonsense-mediated mRNA decay.
    Nickless A; Jackson E; Marasa J; Nugent P; Mercer RW; Piwnica-Worms D; You Z
    Nat Med; 2014 Aug; 20(8):961-6. PubMed ID: 25064126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human disease-causing mutations result in loss of leiomodin 2 through nonsense-mediated mRNA decay.
    Pappas CT; Mayfield RM; Dickerson AE; Mi-Mi L; Gregorio CC
    PLoS Genet; 2024 May; 20(5):e1011279. PubMed ID: 38748723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Frameshift Variant of the ELF4 Gene in a Patient with Autoinflammatory Disease: Clinical Features, Transcriptomic Profiling and Functional Studies.
    Sun L; Han Y; Li B; Yang Y; Fang Y; Ren X; An L; Hou X; Fan H; Wu Y
    J Clin Immunol; 2024 May; 44(6):127. PubMed ID: 38773005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape.
    Cook AL; Sur S; Dobbyn L; Watson E; Cohen JD; Ptak B; Lee BS; Paul S; Hsiue E; Popoli M; Vogelstein B; Papadopoulos N; Bettegowda C; Gabrielson K; Zhou S; Kinzler KW; Wyhs N
    bioRxiv; 2023 Dec; ():. PubMed ID: 38234817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global impact of aberrant splicing on human gene expression levels.
    Fair B; Najar CBA; Zhao J; Lozano S; Reilly A; Mossian G; Staley JP; Wang J; Li YI
    bioRxiv; 2023 Oct; ():. PubMed ID: 37745605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiling of individual FDA-approved clinical drugs identifies modulators of nonsense-mediated mRNA decay.
    Zhao J; Li Z; Puri R; Liu K; Nunez I; Chen L; Zheng S
    Mol Ther Nucleic Acids; 2022 Mar; 27():304-318. PubMed ID: 35024243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reclassification of variants of tumor suppressor genes based on Sanger RNA sequencing without NMD inhibition.
    Ha C; Jang JH; Kim YG; Kim JW
    Front Genet; 2023; 14():1283611. PubMed ID: 37900184
    [No Abstract]   [Full Text] [Related]  

  • 15. Two Novel Frameshift Mutations in the
    Guo X; Shi T; Lin M; Liu B; Pan Y
    Genet Test Mol Biomarkers; 2023 Sep; 27(9):299-305. PubMed ID: 37768332
    [No Abstract]   [Full Text] [Related]  

  • 16. Predisposition gene identification in common cancers by exome sequencing: insights from familial breast cancer.
    Snape K; Ruark E; Tarpey P; Renwick A; Turnbull C; Seal S; Murray A; Hanks S; Douglas J; Stratton MR; Rahman N
    Breast Cancer Res Treat; 2012 Jul; 134(1):429-33. PubMed ID: 22527104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic analysis of variants escaping nonsense-mediated decay uncovers candidate Mendelian diseases.
    Torene RI; Guillen Sacoto MJ; Millan F; Zhang Z; McGee S; Oetjens M; Heise E; Chong K; Sidlow R; O'Grady L; Sahai I; Martin CL; Ledbetter DH; Myers SM; Mitchell KJ; Retterer K
    Am J Hum Genet; 2024 Jan; 111(1):70-81. PubMed ID: 38091987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The global landscape of intron retentions in lung adenocarcinoma.
    Zhang Q; Li H; Jin H; Tan H; Zhang J; Sheng S
    BMC Med Genomics; 2014 Mar; 7():15. PubMed ID: 24646369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Allele-Specific Expression Uncovers Breast Cancer Genes Dysregulated by Cis Noncoding Mutations.
    Przytycki PF; Singh M
    Cell Syst; 2020 Feb; 10(2):193-203.e4. PubMed ID: 32078798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated meta-analysis approach to identifying medications with potential to alter breast cancer risk through connectivity mapping.
    Thillaiyampalam G; Liberante F; Murray L; Cardwell C; Mills K; Zhang SD
    BMC Bioinformatics; 2017 Dec; 18(1):581. PubMed ID: 29268695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.